Erfan Media

Candidate Records / Greg Abbott / Medicare En español

Greg Abbott on Medicare: The One Big Beautiful Bill Act's End to Medicare for Some Immigrants, Cuts to Premium Help, and Drug Negotiation Exemptions

Greg Abbott urged Congress on May 22, 2025 to get the One Big Beautiful Bill Act "to the finish line," a law that, KFF says, marks "the first time that Congress has eliminated Medicare coverage" for people who were legally eligible: refugees, people granted asylum and others without green cards lose Medicare, with the first group's coverage ending February 1, 2027.

The same law blocks two rules that eased enrollment in Medicare premium assistance, exempts more drugs from Medicare price negotiation at a cost of $8.8 billion, and lowers the revenue of Medicare's hospital trust fund. About 4.77 million Texans are on Medicare.

Greg Abbott's Statement on the Law and What It Does to Medicare

What the Medicare Changes Greg Abbott Backed Mean for Older Texans

Frequently Asked Questions About Greg Abbott on Medicare

What is Greg Abbott's record on Medicare under Trump?

Greg Abbott urged Congress in May 2025 to finish the One Big Beautiful Bill Act, a law that ends Medicare for some lawfully present immigrants starting in early 2027, blocks rules that helped low-income seniors get premium help, exempts more drugs from Medicare price negotiation and lowers the hospital trust fund's revenue. In Texas, 4.77 million people are on Medicare.

Did the law Greg Abbott backed cut Medicare?

Yes, for some enrollees: Greg Abbott urged Congress to finish a law that ends Medicare for immigrants who are in the country legally but do not hold green cards, such as refugees. Justice in Aging, an advocacy group for low-income older adults, notes that many of them "have lived, worked, and paid Medicare and other taxes in the U.S. for decades."

What has Greg Abbott done on Medicare drug prices?

Greg Abbott urged Congress to finish the One Big Beautiful Bill Act, which exempts more orphan drugs from Medicare price negotiation. KFF reports that in 2023 Medicare and beneficiaries spent $17.5 billion on the drugs the change covers, and that the exemption will delay selection of Keytruda and Opdivo, two widely used cancer drugs.

Last updated: 2026-10-26

Candidate Records